A READY-TO-USE, INTEROPERABLE METADATA DRIVEN AI PLATFORM
Automates study build, enables robust governance through cross-departmental data lineage and rapidly transforms and generates submission-ready datasets
TCS ADD™ platform received recognition for leveraging automation, AI, and IoT for digitally transforming clinical trials.
Integrated standards and study build
Single source of data in a central repository with cross-departmental data lineage
Intuitive mapping enabling SDTM setup even before the start of trial
Impact analyser that assesses effect of any change by referencing its metadata lineage
Pharma organizations need to improve standard compliance and governance through automation.
Across the entire study build process, pharma companies deal with non-standard data, manual programming, and disjointed downstream processing that lead to increased process time of the study data tabulation models (SDTM). As a result, pharma companies are looking for an automated and integrated, metadata-driven, end-to-end solution leveraging clinical standards as the driving force.
Metadata repository for multiple templates and standards, cross-study, and product reusability
Automated study design from standards and templates with bidirectional integration to EDC such as RAVE and Inform
Automated creation of ready-to-use submission packages using cognitive technologies such as AI and ML
Intuitive metrics to assess the usability of standards
TCS ADD™ wins the 2021 India Pharma award
TCS ADD™ Safety wins the 2020-21 Awards.AI for using AI to re-imagine pharmacovigilance
TCS ADD™ Connected Clinical Trials platform wins the 2020 Citeline Award
TCS' ADD™ Connected Clinical Trials platform wins the European Innovations Award